Difference between revisions of "Team:Aachen/Lab/Glycogen/Characterization"
m (→Dinitrosalicylic Acid Staining) |
Lhelleckes (Talk | contribs) (→How We Approached Glycogen Characterization) |
||
(13 intermediate revisions by 5 users not shown) | |||
Line 4: | Line 4: | ||
__NOTOC__ | __NOTOC__ | ||
After building our mono- and polycistronic constructs, their characterization was the next and possibly most important step. In this process, we investigated both cell growth and glycogen formation to prove the accumulation of glycogen due to the overexpression of glycogen building genes and the knockout of glycogen degradation genes. | After building our mono- and polycistronic constructs, their characterization was the next and possibly most important step. In this process, we investigated both cell growth and glycogen formation to prove the accumulation of glycogen due to the overexpression of glycogen building genes and the knockout of glycogen degradation genes. | ||
− | In our approaches, we wanted to examine the function of ''glgCAB'', draw conclusions on fermentation conditions and estimate the increase in glycogen. Therefore, we did growth experiments with ''Escherichia coli'' BL21 Gold (DE3) and analysed respective samples via [[Team:Aachen/Notebook/Protocols#Iodine_Staining|iodine staining]] and [[Team:Aachen/Notebook/Protocols#Dinitrosalicylic_Acid_Staining| dinitrosalicylic acid staining]]. Furthermore, we did glycogen purifications to apply a [[Team:Aachen/Notebook/Protocols#Glycogen_Kit|glycogen kit]]. | + | In our approaches, we wanted to examine the function of ''glgCAB'', draw conclusions on fermentation conditions and estimate the increase in glycogen. Therefore, we did growth experiments with ''Escherichia coli'' BL21 Gold (DE3) and analysed respective samples via [[Team:Aachen/Notebook/Protocols#Iodine_Staining|iodine staining]] and [[Team:Aachen/Notebook/Protocols#Dinitrosalicylic_Acid_Staining| dinitrosalicylic acid staining]]. Furthermore, we did glycogen purifications to apply a [[Team:Aachen/Notebook/Protocols#Glycogen_Kit|glycogen kit]]. |
− | + | ==Achievements== | |
{|class="wikitable" | {|class="wikitable" | ||
Line 19: | Line 19: | ||
|[http://parts.igem.org/Part:BBa_K1585310 K1585310]|| ''glgA'' || characterized monocistronic BioBrick by iodine staining | |[http://parts.igem.org/Part:BBa_K1585310 K1585310]|| ''glgA'' || characterized monocistronic BioBrick by iodine staining | ||
|- | |- | ||
− | |[http://parts.igem.org/Part: | + | |[http://parts.igem.org/Part:BBa_K1585311 K1585311]|| ''glgB'' || characterized monocistronic BioBrick by dinitrosalicylic acid staining |
|- | |- | ||
|[http://parts.igem.org/Part:BBa_K1585351 K1585351]|| Δ''glgP'' || characterized gene knockout by iodine staining | |[http://parts.igem.org/Part:BBa_K1585351 K1585351]|| Δ''glgP'' || characterized gene knockout by iodine staining | ||
Line 39: | Line 39: | ||
− | + | The ''glgC'' BioBrick, based on BBa_K118016 by Team Edinburg 2008, was fused with the well-characterized RBS B0034. The dark color shows that the strong effect of GlgC on glycogen accumulation was preserved. | |
Line 65: | Line 65: | ||
=Dinitrosalicylic Acid Staining= | =Dinitrosalicylic Acid Staining= | ||
− | The | + | The iodine staining of strains containing ''glgB'' (branching enzyme) was not quite distinct. We still wanted to investigate the functionality of the strains. Therefore, we used [[Team:Aachen/Notebook/Protocols#Dinitrosalicylic_Acid_Staining| dinitrosalicylic acid staining (DNS)]] for detection of reducing ends <ref>S. K. Meur, V. Sitakara Rao, and K. B. De. Spectrophotometric Estimation of Reducing Sugars by Variation of pH. Z. Anal. Chem. '''283''', 195-197 (1977)</ref> which should correspond to the branching frequency. All samples of ''glgB'' strains were compared to wild type samples. For best comparison the samples were grown to stationary phase and adjusted to the same OD before staining. Since every sugar or alkyl would have reacted with 3,5-dinitrosalicylic acid, we purified our samples before the staining. In order to identify the branching frequency, we analyzed the absorbance values of the purified samples compared to the absorbance values of hydrolyzed samples. By calculating the absorbance ratio of the non-hydrolyzed divided by the hydrolyzed samples, we aimed for information about the branches per glycogen unit. |
+ | The reaction principle can be described as follows. | ||
− | {{Team:Aachen/Figure|Aachen_GlycogenDNS_assay_reaction_scheme.png|title=reaction principle|size= | + | {{Team:Aachen/Figure|Aachen_GlycogenDNS_assay_reaction_scheme.png|title=reaction principle|size=large}} |
<span style="color:transparent">a</span> | <span style="color:transparent">a</span> | ||
− | 3,5-Dinitrosalicylic acid reacts with the reducing ends to 3-Amino-5-Nitrosalicylic acid, resulting in a changed π-system. During the reaction, the reducing ends are oxidized | + | 3,5-Dinitrosalicylic acid reacts with the reducing ends to 3-Amino-5-Nitrosalicylic acid, resulting in a changed π-system and therefore a change in absorbance. During the reaction, the reducing ends are oxidized whereas one nitro group of 3,5-Dinitrosalicylic acid is reduced to an amino group of 3-Amino-5-Nitrosalicylic acid. The more free reducing ends are present the more 3-Amino-5-Nitrosalicylic acid will be formed. Thus, the absorbance will increase. |
==Results from Dinitrosalicylic Acid Staining== | ==Results from Dinitrosalicylic Acid Staining== | ||
− | The absorbance of non-hydrolyzed samples of the ''glgB'' strain is higher than the absorbance of the wild type (see figure ''DNS staining of hydrolyzed samples of the ''glgB'' strain and wild type''). To identify the amount of glycogen in the samples, we hydrolyzed the samples. Our results show that the | + | The absorbance of non-hydrolyzed samples of the ''glgB'' strain is higher than the absorbance of the wild type (see figure ''DNS staining of hydrolyzed samples of the ''glgB'' strain and wild type''). To identify the amount of glycogen in the samples, we hydrolyzed the samples and applied our staining. Our results show that the number of branches in glycogen is higher in the ''glgB'' strain compared to the wild type (''DNS staining of non-hydrolyzed samples of the ''glgB'' strain and wild type''). |
− | {{Team:Aachen/DoubleFigure|Aachen GlycogenDNSNotHydrolyzed.png|Aachen GlycogenDNSHydrolyzed.png|title1=DNS staining of non-hydrolyzed samples of the ''glgB'' strain and wild type|title2=DNS staining of hydrolyzed samples of the ''glgB'' strain and wild type|subtitle1=The non-hydrolyzed samples of the ''glgB'' strain and wild type show that the overexpression of ''glgB'' leads to glycogen molecules with a higher number of branches compared to the wild type. Error bars show propagation of uncertainty.|subtitle2=The hydrolyzed samples indicate that the glycogen amount is higher in the wild type compared to the ''glgB'' strain. Error bars show propagation of uncertainty.|size=medium}} | + | {{Team:Aachen/DoubleFigure|Aachen GlycogenDNSNotHydrolyzed.png|Aachen GlycogenDNSHydrolyzed.png|title1=DNS staining of non-hydrolyzed samples of the ''glgB'' strain and wild type|title2=DNS staining of hydrolyzed samples of the ''glgB'' strain and wild type|subtitle1=The non-hydrolyzed samples of the ''glgB'' strain and wild type show that the overexpression of ''glgB'' leads to glycogen molecules with a higher number of branches compared to the wild type. Error bars show propagation of uncertainty.|subtitle2=The hydrolyzed samples indicate that the glycogen amount is higher in the wild type compared to the ''glgB'' overexpressing strain. Error bars show propagation of uncertainty. Since cell fragments are still left in the samples, the blank also shows an absorbance. Therefore, the line does not go though the origin.|size=medium}} |
<span style="color:transparent">a</span> | <span style="color:transparent">a</span> | ||
− | The non-hydrolyzed values divided by the hydrolyzed values generate a ratio. Based on this ratio we can identify the number of branches per glycogen unit. It indicates that the number of branches per unit is higher in the ''glgB'' strain compared to the wild type. | + | The non-hydrolyzed values divided by the hydrolyzed values generate a ratio. Based on this ratio we can identify the number of branches per glycogen unit. It indicates that the number of branches per unit is higher in the ''glgB'' strain compared to the wild type. |
− | {{Team:Aachen/DoubleFigure|Aachen GlycogenDNSRatio.png|Aachen_GlycogenDNSCalibration.png|title1=ratio of non-hydrolyzed and hydrolyzed DNS staining values of the ''glgB'' strain and wild type|title2=glycogen calibration curve|subtitle1=Although the amount of glycogen is higher in the wild type (see figure above), the number of branches per glycogen unit is higher in the ''glgB'' strain. | + | |
− | The results of our experiments show that the overexpression of ''glgB'' leads to glycogen molecules with a higher number of branches compared to the wild type. | + | {{Team:Aachen/DoubleFigure|Aachen GlycogenDNSRatio.png|Aachen_GlycogenDNSCalibration.png|title1=ratio of non-hydrolyzed and hydrolyzed DNS staining values of the ''glgB'' strain and wild type|title2=glycogen calibration curve|subtitle1=Although the amount of glycogen is higher in the wild type (see figure above), the number of branches per glycogen unit is higher in the ''glgB'' overexpressing strain. Therefore the overexpression of ''glgB'' successfully increased the number of branches. Error bars show propagation of uncertainty.|subtitle2=With the calibration curve we are able to identify the glycogen concentration of our samples. Error bars show propagation of uncertainty.|size=medium}} |
+ | |||
+ | <span style="color:transparent">a</span> | ||
+ | |||
+ | |||
+ | The results of our experiments show that the overexpression of ''glgB'' leads to glycogen molecules with a higher number of branches compared to the wild type. Therefore, we proved the functionality of our ''glgB'' BioBrick. | ||
<span style="color:transparent">a</span> | <span style="color:transparent">a</span> |
Latest revision as of 03:49, 19 September 2015